Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT3 | O60678 | 1/20 | 0.58 |
| ▸ | EP300 | Q09472 | 1/20 | 0.58 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.58 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | CA3 | P07451 | 1/20 | 0.57 |
| ▸ | ENPP2 | Q13822 | 9/20 | 0.51 |
| ▸ | CD40 | P25942 | 1/20 | 0.50 |
| ▸ | CD40LG | P29965 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | AMY1A | P0DUB6 | 4/20 | 0.43 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31519881 | 1.00 | PRMT3 (0.58) | PRMT3EP300PRMT6PRMT1CA2 | |
| SCHEMBL14529309 | 1.00 | PRMT3 (0.58) | PRMT3EP300PRMT6PRMT1CA2 | |
| SCHEMBL29660882 | 0.94 | PRMT1 (0.67) | PRMT3EP300PRMT6PRMT1CA2 | |
| SCHEMBL10611415 | 0.94 | PRMT1 (0.67) | PRMT3EP300PRMT6PRMT1CA2 | |
| SCHEMBL10611423 | 0.94 | PRMT1 (0.67) | PRMT3EP300PRMT6PRMT1CA2 | |
| SCHEMBL5000592 | 0.92 | PRMT3 (0.56) | PRMT3EP300PRMT6PRMT1CA2 | |
| SCHEMBL29660624 | 0.92 | PRMT3 (0.56) | PRMT3EP300PRMT6PRMT1CA2 | |
| SCHEMBL5000589 | 0.92 | PRMT3 (0.56) | PRMT3EP300PRMT6PRMT1CA2 | |
| SCHEMBL20483012 | 0.89 | THRB (0.63) | PRMT3EP300PRMT6PRMT1CA2 | |
| SCHEMBL523942 | 0.89 | THRB (0.63) | PRMT3EP300PRMT6PRMT1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| US-20070271711-A1 | Dye Mixtures of Fibre-Reactive Azo Dyes Production and Use Thereof | DYSTAR TEXTILFARBEN GMBH & CO., DEUTSCHLAND KG (DE) | 2007-11-29 | — | — | US | disclosed |
| WO-2007039573-A2 | AZO REACTIVE DYES AND MIXTURES OF FIBER-REACTIVE AZO DYES, THEIR PREPARATION AND THEIR USE | DYSTAR TEXTILFARBEN GMBH & CO DEUTSCHLAND KG (DE) | 2007-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | KRT18, KLK3, KLKB1 | PRMT3 1298/4885EP300 3664/4885PRMT6 1727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.